Bayh: Device tax a job-killing 'raid' on the industry; Illumina, Life take aim at Roche with Dx buys;

 @FierceMedDev: Boston Scientific won a CE mark for a Deep brain stimulation treatment of Parkinson's disease. More | Follow @FierceMedDev

 @MarkHFierce: Finally--the deal is done. Sony is officially investing $645M into Olympus and the two will partner on medical equipment. More | Follow @MarkHFierce

 @DamianFierce: The FDA is getting an earful from lawmakers over the hackability of medical devices. More | Follow @DamianFierce

> Former Democratic U.S. Sen. Evan Bayh of Indiana says the 2.3% device industry tax represents a "raid" on the industry and will threaten thousands of American jobs. Opinion (WSJ sub. req)

> With their recent diagnostics M&A activity, Illumina ($ILMN) and Life Technologies ($LIFE) are taking aim at diagnostics giant Roche ($RHHBY), Bloomberg says. Article

> Cook Medical unveiled a new distribution center in Baisweiler, Germany intended to serve as a delivery hub for its European business. Release

> Freedom Meditech obtained a $2 million line of credit to help ramp up manufacturing and distribution of its chronic disease detection device, pending regulatory approval. Story

> Ethicon is launching its next generation of powered endocutters for laparoscopic surgeries in the chest cavity. News

> Medical device company VBOX got FDA clearance for its Trooper wearable oxygen concentrator, designed to fit in a purse and allow patients greater freedom than other oxygen-providing devices. More

> Abbott Laboratories ($ABT) is just about ready to split in two, but the company hit a PR snag: Richard Gonzalez, the man tabbed to head pharma-focused AbbVie, may not have been entirely honest on his résumé. Report

Biotech News

 @FierceBiotech: The French government wants Sanofi 'guarantees' on the future of Toulouse R&D. More | Follow @FierceBiotech

 @JohnCFierce: Paratek - Ph3 antibiotic, lost a big Novartis deal last year - wants a $92M IPO? Hmmmm. More | Follow @JohnCFierce

 @RyanMFierce: A crisis of credentials? Abbott came clean that choice to lead pharma unit didn't finish college. More | Follow @RyanMFierce

> IPO priced for biotech working on drug against chin fat. Story

> UCB fails to set RA drug apart from Roche med in Phase II. More

> Novo Nordisk scuttles late-stage hemophilia drug over patient risk. Article

Pharma News

@FiercePharma: Japan OKs Novo Nordisk's long-acting insulin Tresiba, still awaiting decision from FDA. More | Follow @FiercePharma

> Roche should pick up AbbVie or BMS, analyst thinks. Story

> Regeneron keeps keeping on with Eylea. Article

> FDA tries to protect public from fake Internet pharmacies. News

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.